James M Mckearin

Title: James M Mckearin: Innovator in Nicotinamide Mononucleotide Derivatives

Introduction

James M Mckearin is a notable inventor based in the United States. He has made significant contributions to the field of biochemistry, particularly in the development of nicotinamide mononucleotide derivatives. His work focuses on the potential therapeutic applications of these compounds in promoting cellular health.

Latest Patents

James M Mckearin holds a patent for "Nicotinamide Mononucleotide Derivatives And Their Uses." This invention relates to compositions of nicotinamide mononucleotide derivatives and their methods of use. The invention also encompasses methods for preparing these derivatives. Furthermore, it includes pharmaceutical compositions and nutritional supplements containing nicotinamide mononucleotide derivatives. The methods described in the patent aim to increase intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues, which can be beneficial for treating diseases and enhancing cell and tissue survival.

Career Highlights

James M Mckearin is associated with Metro International Biotech, LLC, where he applies his expertise in biochemistry to advance research and development in the field. His innovative work has the potential to impact various health-related applications.

Collaborations

James has collaborated with notable professionals in his field, including Karl D Normington and David Andrew Sinclair. These collaborations have likely contributed to the advancement of research in nicotinamide mononucleotide derivatives.

Conclusion

James M Mckearin is a prominent figure in the development of nicotinamide mononucleotide derivatives, with a focus on their therapeutic uses. His contributions to the field of biochemistry are noteworthy and have the potential to improve health outcomes.